In this study we tested the hypothesis that type 2 diabetes impairs the dynamic response of leg vascular conductance (LVC) during exercise. LVC (leg blood flow/mean arterial pressure) responses were studied during intermittent contractions of the calf muscle in subjects with type 2 diabetes (n = 9), heavy controls (n = 10) and lean controls (n = 8) using a biexponential function and an estimate of the mean response time (MRT). The time constant of the second phase of LVC was significantly greater in type 2 diabetes (66.4 ± 29.2 s) than the heavy (22.2 ± 13.4 s) and lean (21.8 ± 9.3 s) controls, resulting in a significantly greater MRT in the diabetic group (median ] s). These data support the hypothesis and suggest that a slowed hyperaemic response in the exercising limb might contribute to exercise intolerance in diabetic subjects.
Introduction
Exercise intolerance is a major complication of type 2 diabetes [1] [2] [3] [4] that is associated with increased mortality. 5 Although the aetiology of exercise intolerance in type 2 diabetes is not well understood, both a reduction in peak O 2 uptake (Vo 2 ) [1] [2] [3] [4] and a profound slowing of the dynamic response of Vo 2 during submaximal exercise 3, 6 have been observed in patients with type 2 diabetes. These data are consistent with the exaggerated fall in muscle PCr and pH during calf exercise in type 2 diabetes, 7 suggesting that mechanisms underlying the control of Vo 2 are impaired in this disease.
The control of the dynamic response of Vo 2 during exercise is considered important to the process of fatigue and tolerance of exercise. 8 The control of Vo 2 depends, to some extent, on the control of O 2 delivery and muscle blood flow. 9, 10 Recent evidence of a lower muscle blood flow during steady-state, submaximal exercise 2, 11 raises the possibility that the dynamic control of muscle blood flow is impaired in type 2 diabetes. This would help explain both the larger rise in the NIRS-derived deoxygenated haemoglobin in contracting muscle observed in type 2 diabetes 6 and the faster decline in 'microvascular PO 2 ' during twitch contractions in the streptozotocin-induced diabetic rat. 12 However, steady-state measures of limb blood flow shed little light on the dynamic response prior to these measurements, 13 and it is not known if the dynamic response
Methods Subjects
Nine women with type 2 diabetes, 10 overweight but otherwise healthy women ('heavy controls') and 8 lean and healthy women ('lean controls') volunteered to participate in this study. Healthy subjects were recruited from Trinity College Dublin and diabetic subjects were recruited from the Diabetes Unit at St Colmcilles Hospital, Dublin. Exclusion criteria for participation in this study included (1) a diagnosis of peripheral arterial disease (ankle:brachial pressure index < 0.9), hypertension (systolic blood pressure > 140 mmHg), coronary heart disease (described in the following), neuropathy or retinopathy, (2) were smokers or had smoked during the 12-month period preceding the study or (3) were taking insulin, beta-blockers, calcium channel blockers or any other antihypertensive drugs. All diabetic subjects had a clinical history of diabetes that ranged between 1 and 4 years; but immediately prior to the study did not have clinical evidence of ischaemic heart disease (normal ECG during treadmill stress test) or renal and hepatic dysfunction (urinary protein < 200 mg dl -1 ; urinary creatinine levels < 2.2 mg dl -1 ). Physical characteristics of the subjects are shown in Table 1 . Prior to and during this study the diabetic subjects were taking either metformin (n = 5), avandmen (n = 1), statins (n = 3) and/or an angiotensin-converting enzyme (ACE) inhibitor (n = 1). None of the subjects were taking contraceptive drugs during this period. Subjects were both premenopausal (n = 11: 4 diabetic, 4 heavy and 3 lean) and postmenopausal (n = 16: 5 diabetic, 6 overweight and 5 lean) whose ages ranged between 34 and 69 years. All premenopausal subjects were tested during days 7-10 of their menstrual cycle. Subjects were classified as sedentary (≤1 hour week -1 of moderate intensity exercise in the preceding 3 months), which was confirmed using the Low Level Physical Activity Recall (LOPAR) questionnaire. 20, 21 All subjects provided informed consent prior to their participation in this study, and the study was approved by the institutional ethics committee and conducted in accordance with the Declaration of Helsinki (2008) .
Experimental overview
Subjects were tested on 2 days. On the first day they were familiarised with calf exercise and the protocol to be completed on the second day, and then they completed a series of maximum efforts for the determination of maximum voluntary force (MVC). On the second day they performed three bouts of high-intensity calf exercise during which leg blood flow, mean arterial pressure and leg vascular conductance were recorded. All tests were conducted at the same time of the day (i.e. mid morning) and same ambient temperature (i.e. 21°C). Subjects did not consume alcohol and caffeine during a 24-hour period, or perform intense exercise for a 48 hour period, immediately before the testing sessions.
Calf exercise
Single-leg calf exercise was performed in an inclined position (67 o ) on a custom-built ergometer described previously by us. 18 For both the determination of MVC and the repeated bouts of calf exercise, subjects were tilted rapidly from the supine position and then initiated contractions within ~5 s of reaching the inclined position. The calf MVC was determined as the highest force during a series of five maximal contractions, each separated by 60 s of rest in the supine position. Then, on a following day, the subject rested for 20 min in the supine position during which resting cardiovascular measurements were made (see the 'Leg vascular conductance' section), before being tilted upright to the inclined position and commencing calf exercise soon after. 18 Calf exercise consisted of intermittent and static contractions of the calf muscle (6 s duty cycle: 2 s contraction, 4 s relaxation) at a target force of 70% MVC. Each subject performed three calf exercise trials, separated by 20-30 min of rest in the supine position, and the duration of each exercise trial was 6 minutes.
Leg vascular conductance
Estimates of leg vascular conductance (LVC) during rest and calf exercise were based on simultaneous measurements ), a position that was felt to better represent the haemodynamic conditions under which these muscles work during daily activities (e.g. walking) than the supine position. Although it would have been preferable to make both resting and exercise measurements in the inclined position, it is difficult to obtain stable estimates of leg blood flow soon after tilting to the upright position, as leg blood flow increases rapidly during tilting and can take several minutes to stabilise when in the tilted position. 18 Moreover, our pilot studies 18 showed that resting on the ergometer in the inclined position for several minutes often caused profound leg swelling and discomfort.
During calf exercise, leg blood flow, MAP and, thus, LVC were measured during each period of relaxation between contractions. 18 For each of the three exercise trials this yielded 60 measurements of these three variables. Leg blood flow was measured during calf exercise using venous occlusion strain-gauge plethysmography, 18 a technique which provides similar estimates of limb blood flow during exercise when compared with Doppler ultrasound. 22 Briefly, a thigh cuff was inflated before exercise and maintained throughout exercise at a pressure of 55 mmHg. Leg blood flow was then assessed during the 4-s relaxation periods between contractions by measuring the change in leg volume ( Figure 1 ) using a mercury-in-Silastic strain gauge, placed around the widest girth of the calf, and a plethysmograph (Hokanson EC-6, Washington, USA). The plethysmographic estimates of leg blood flow, normally expressed relative to the resting limb volume (ml 100 ml -1 min -1 ), were converted to millilitres per minute using an estimate of each subject's leg volume obtained from anthropometric measurements of the leg.
23 These blood flow estimates were then normalised to the mean force (N) produced immediately before its measurement (ml
). MAP was measured beat by beat at rest and during exercise using applanation tonometry of the radial artery (COLIN CBM7000, Japan). There were no significant differences between these tonometric MAP values and those obtained on the contralateral arm every 2 minutes using an oscillometric method (Omron M7). LVC during exercise was calculated by dividing leg blood flow by the simultaneous measurement of MAP plus the estimated hydrostatic pressure acting at the midpoint of the calf in this inclined position.
18, 24

Dynamic response characteristics of LVC
LVC responses (scaled to force) from the three exercise trials were averaged to yield a temporal profile of LVC based on 60 averaged estimates for each subject (an example is shown later in Figure 4 ). Of the 27 individual responses, 22 of them exhibited a clear biphasic pattern and the remaining five responses more closely resembled a monophasic (two heavy control subjects) or triphasic pattern (one lean control, one heavy control, one diabetic subject). On this basis, the LVC responses of all subjects were fitted using a biphasic function and the impact that deviations in measured responses from this biphasic response (in the case of five subjects) has on interpretation of the data is dealt with in the Discussion. The biphasic response was represented by the biexponential function
where a represents LVC at t = 0, and the amplitude, time delay and time constant of the first and second phases are represented by A1-A2, TD1-TD2 and t1-t2, respectively. The parameters U1 and U2 are conditional expressions that limit the fitting of a particular phase to the period at and beyond the time delay associated with that phase. Data that exceeded the 95% prediction intervals during an initial fit of a model were excluded, and no more than four data points were removed from the original time series of data. The models were fitted to the data using a weighted least-squares nonlinear regression procedure (LevMarqdt, TableCurve 2D, Jandel Scientific).
A graphic illustration of this biphasic model is shown in Figure 2 . The magnitude of the first phase of the LVC response is defined by the parameter A1, and the temporal response of this phase is defined with respect to its onset relative to the start of exercise (i.e. the time delay TD1) and The voltage change between two contractions is shown between the dashed vertical lines, and this voltage change is converted to a volume change relative to the resting limb volume (in ml 100 ml -1 ) using an electronic calibration internal to the plethysmograph. Leg blood flow is then calculated from this volume change and the period over which it occurs (see Methods for further explanation).
its rate of increase towards its asymptotic value (t1). This first phase is rapidly responding (small TD and t) and usually complete within ~10 s. The magnitude of the second phase is defined by parameter A2, its onset is delayed relative to the onset of the first phase (i.e. TD2) at ~20-30 s after exercise onset, and its rate of rise towards its asymptotic value (t2) is generally slower than that of the first phase. The impact that the combined effect that both phases has on the size and speed of the overall LVC response for each subject can be represented by an 'end-exercise' response (i.e. LVC at t = 360 s) and a mean response time (MRT) calculated using the fitted biphasic function. The MRT, which represents the time to reach ~63% of the overall amplitude of the response from the baseline value, was calculated as a weighted sum of the time delay and time constant of each phase:
Heart rate Heart rate was measured from the R-R interval of singlelead (lead II) ECG at rest and every 5 s during each of the three calf exercise trials and averaged to yield a single time series of heart rate data for each subject. The dynamic response of heart rate during calf exercise was fitted using a monoexponential function:
Heart rate (t) = a + A(1 -e
where a is the baseline heart rate, A is the amplitude of the exercise response, TD is the delay in rise of heart rate after exercise onset and t is the time constant of the response. The fitting procedures were identical to that described for LVC, and because the dynamic structure of the heart rate response was not as consistent between subjects as the LVC response, a relatively simpler, monophasic function was chosen.
Statistics
Cardiovascular data at rest and during exercise were compared between the three groups of subjects using a oneway analysis of variance (ANOVA) and differences were located using Tukey's post hoc test (SigmaStat 3.5, Systat, USA). Data that were not normally distributed were analysed using a Kruskal-Wallis test and multiple comparisons were then performed using Dunn's method. The level of significance was set at p ≤ 0.05. Results are shown as either mean ± SD for data that were normally distributed or as median and interquartile ranges for data that were not normally distributed.
Results
Calf exercise
There were no significant differences in MVC between the three groups ( Table 1 ). The submaximal force sustained during calf exercise and averaged across all contractions was not significantly different between subjects with type 2 diabetes (66% ± 4% MVC), heavy controls (70% ± 3% MVC) and lean controls (67% ± 5% MVC).
Haemodynamic measurements
Plethysmographic measurements of resting blood flow were not different between the diabetic (1.78 ± 0.40 ml 100 ml -1 min -1 ), heavy control (1.56 ± 0.57 ml 100 ml -1 min -1 ) and lean control (1.69 ± 0.63 ml 100 ml -1 min -1 ) groups. Leg blood flow was converted to units of ml min -1 using anthropometric estimates of leg volume and then used to measure leg blood flow and LVC at rest and during exercise, as reported in Table 2 and Figure 3 . There were no significant differences in leg blood flow, MAP or LVC measurements at rest, at 20 s into exercise or at the end of exercise between the three groups ( Table 2) . Although calf exercise evoked a significant increase in MAP in all three groups, this effect was small (~5-6 mmHg) and not different between the groups. The group-averaged responses of leg blood flow, MAP and LVC during calf exercise are shown in Figure 3 . Representative LVC responses scaled to force, as well as responses predicted from the fitting of the biphasic function, are shown in Figure 4 . Parameter estimates defining the biphasic response of LVC, as well as the MRT and end-exercise values calculated using these parameter estimates, are shown in Table 3 . The goodness of fit, as reflected in the adjusted R 2 value, was similar between the type 2 diabetes (0.77 ± 0.11), heavy control (0.78 ± 0.18) and lean control (0.76 ± 0.23) groups. The MRT was significantly larger (p < 0.05) in type 2 diabetes than the control groups; whereas the end-exercise values were similar between the three groups. The time constant of the second phase (t2) was also significantly larger in type 2 diabetes than controls. None of the remaining parameters were significantly different between the groups, although the parameter TD1 tended to be different between the groups (ANOVA, p = 0.06).
Heart rate
The baseline or resting heart rate (parameter a) immediately before calf exercise was not significantly different between the type 2 diabetes (67 ± 11 bpm), heavy control (67 ± 8 bpm) and lean control (61 ± 8 bpm) groups. When comparing the dynamic response characteristics of heart rate between these three groups (type 2 diabetes versus heavy versus lean), there were no significant differences in the amplitude (parameter A: 17.3 ± 4.4 versus 14.5 ± 4.7 versus 14.7 ± 8.4 bpm), time delay (parameter TD: 0.2 ± 0.6 versus 0.2 ± 0.3 versus 2.2 ± 3.5 s) or time constant (parameter t: 6.7 ± 5.1 versus 11.8 ± 17.9 versus 14.2 ± 16 s).
Discussion
A major finding of the present study is that, compared with both lean and heavy controls, the response of LVC and blood flow during calf exercise was profoundly slowed in type 2 diabetes patients. In contrast, the response of MAP during exercise was not different between these three groups. This slowing of the hyperaemic response, evident in a significantly larger MRT for LVC, can be attributed entirely to the slower rate of increase (i.e. larger time constant) of the second phase of the hyperaemic response; whereas the first phase was unaffected by type 2 diabetes. The similar LVC and blood flow responses between lean and heavy controls suggests that obesity per se is not responsible for the impaired hyperaemic response in type 2 diabetes.
Dynamic response characteristics of leg vascular conductance
In the presence of similar MAP responses between the three groups, the slower leg blood flow response in type 2 diabetes can be attributed to a slower response of LVC ( Figure 3 and, thus, vasodilation in the contracting skeletal muscle. A high frequency of measurements of LVC during exercise combined with empirical modelling of this dynamic response enables the dynamic structure of these phases to be resolved. 14 The dynamic response of each phase is assumed to be an exponential process defined by a set of parameters that include the amplitude, time constant and time delay. It has been suggested that each phase and the parameters which define its structure potentially represent a distinct set of underlying control mechanisms involved in vascular control. 13 In the present study, LVC was modelled using a biexponential function on the basis that a biphasic response was more apparent (22/27 subjects) than either a monophasic or triphasic response. This is consistent with the biphasic response of arteriolar vasodilation to muscle stimulation observed in the hamster cremaster muscle preparation, 25, 26 as well as the biphasic response of forearm blood flow during moderate handgrip exercise. 17 However, as is apparent in forearm vascular conductance responses to handgrip exercise, 17 not all responses can be characterised by the same number of phases. In the present study, two subjects (both heavy controls) exhibited a monophasic response and, thus, the estimated amplitude of the second phase of these responses was zero, whereas three subjects (one from each group) exhibited a triphasic response, and this would result in an overestimate of the amplitude and time constants of the second phase for these subjects. However, neither of these observations can account for the longer time constant of the second phase of the hyperaemic response in the diabetic group compared with the lean or heavy control groups.
Mechanisms of vascular control during exercise
A wide range of mechanisms probably contributes to the biphasic control of vascular conductance in contracting human muscles, although the precise contribution of any one mechanism to either phase is not yet clear. The first phase of vasodilation is initiated in response to the first contraction and is fully expressed within ~10-20 s. 17 Likely mechanisms involved in this initial phase include K + release into the interstitium 27 and mechanical deformation of resistance vessels, 28 as well as acetylcholine release from the motor nerves, 29 although there is some uncertainty regarding its effectiveness in contracting human skeletal muscle. 30, 31 In addition, the increase in the perfusion pressure under the permissive influence of the 'muscle pump' 32 will increase limb blood flow beyond that supported by vasodilation, and it will do so in response to the first contraction and particularly when the limb is well below the level of the heart. 18 The second phase of vasodilation is initiated at ~20-30 s after exercise onset (Table 2) , 17 and it has been suggested that the second phase is a flow-mediated, endotheliumdependent phase 13 that is perhaps linked causally to the decline in muscle PO 2 . 25 It is likely that adenosine, a potent vasodilator in human skeletal muscle, 33 is linked to the decline in muscle PO 2 and contributes to this second phase, 25 despite the uncertainty about its time course of accumulation in the interstitial fluid during the first phase of the hyperaemic response. 34 Both nitric oxide and prostaglandins may be involved in this vascular action of adenosine or contribute independently to the exercise hyperaemic response, 35, 36 although the inhibition of nitric oxide synthesis has little effect on the rise in muscle blood flow during exercise. 31, 37 Both the classic autoregulation (Bayliss mechanism) response and muscle sympathetic nerve activation have the potential to modulate both biphasic responses; but their contributions to the dynamic response characteristics have not, to the best of the authors' knowledge, been established.
Mechanisms of impaired vascular control in diabetes
The slowed hyperaemic response observed in the present study combined with the more rapid decline in muscle microvascular PO 2 and deoxygenated haemoglobin 12, 38 in type 2 diabetes suggests that the speed of the vasodilatory response to a metabolic stimulus is impaired in this disease. In contrast, neither the end-exercise value or phasic amplitudes of LVC were significantly affected by type 2 diabetes ( Table 2 ), suggesting that the capacity to vasodilate under exercise conditions that evoke near-maximal blood flows 18 remains intact. However, the phase 1 amplitude and endexercise value for LVC was 15-20% lower in the diabetic group and, although this difference was not significant, the large between-subject variation in responses might have obscured an important physiological difference which warrants further investigation. Nevertheless, given that the initial hyperaemic response (phase 1) was not significantly affected by type 2 diabetes, the slowed second phase response is probably not due to a lower preceding flow stimulus and above-mentioned mechanisms that underlie it and is perhaps more likely explained by the failure of endothelial-mediated vasodilation to amplify the early rise in vascular conductance.
There are a number of potential mechanisms that underlie vascular dysfunction in type 2 diabetes. 39 Of particular relevance to the present findings is evidence that type 2 diabetes or hyperglycaemia impairs flow-mediated and endothelial-dependent control of vascular resistance in the human forearm. 11, [40] [41] Flow-mediated and endothelialdependent control mechanisms are thought to be central to the time-dependent propagation of vasodilation from distal to more proximal resistance vessels, a critical process in controlling the hyperaemic response during muscle contractions. 42 This process depends on the gap junction intercellular communication between endothelial cells and smooth muscle, 42 a process that is affected by high glucose concentrations. 39 It is tempting to speculate that hyperglycaemiainduced disruption of this cell-to-cell mediated control over the vascular response during exercise contributes to the slowing of the second phase of the hyperaemic response in type 2 diabetes.
To some extent the vascular mechanisms which impair the muscle hyperaemic response in type 2 diabetes might depend on the exercise model used and/or muscles studied. That the amplitudes of the LVC response during high-intensity calf exercise were unaffected by type 2 diabetes is consistent with the maximal vasodilation in the hindlimb of the streptozotocin-induced diabetic rat being similar to control animals. 43 However, they contrast with the lower steady-state values of limb blood flow during lower intensity cycling 11 and knee extension exercise. 2 We can only speculate on the reasons for this discrepancy and which might include both the intensity of exercise (moderate versus 'maximal'), the muscles studied (quadriceps versus calf) and the potential influence of muscle atrophy (if present) on vascular conductance. In addition, the influence of sympathetically mediated vasoconstriction in muscle on exercise hyperaemia in type 2 diabetes warrants further study, since it is increased at rest in an insulin-resistant state 44 and has been proposed as a possible candidate for the age-related blunting of the hyperaemic response to exercise involving the quadriceps muscles. 45 The pharmacotherapy used by the present diabetic group, which includes metformin, statins and ACE inhibitors, is unlikely to account for the vascular dysfunction observed in the present study given that these drugs generally enhance vascular function.
It has been suggested that cardiac dysfunction, a major complication of type 2 diabetes, 7 might contribute to altered blood flow or Vo 2 responses in type 2 diabetes. [1] [2] [3] [4] This, however, seems an unlikely mechanism in the present study given the following: (1) LVC reflects vasodilation in the contracting skeletal muscle; (2) differences in the leg blood flow response is entirely a function of LVC given that the pressor responses were similar between the three groups; (3) the small but significant rise in MAP in the subjects with type 2 diabetes demonstrates that cardiac function is sufficient to maintain blood pressure in the presence of a progressive decline in leg vascular resistance; and (4) there was no difference in the dynamic response of heart rate during calf exercise between the three groups. The common interpretation that a lowered cardiac output or slowed heart rate 'kinetics' observed during exercise in type 2 diabetes reflects cardiac dysfunction [1] [2] [3] [4] is, in the absence of simultaneous arterial pressure measurements, tenuous. An alternative explanation for such cardiac responses is that they reflect vascular dysfunction and altered responses of limb blood flow.
Relevance to VO 2 and exercise tolerance
Like limb blood flow and vascular conductance, Vo 2 increases in a biphasic manner during moderate exercise. Type 2 diabetes slows the second of these two phases of Vo 2 , 3, 6 and we have observed the same effect on Vo 2 kinetics in a sample of women that included many of those who participated in the present study. 46 Given the close temporal alignment between the muscle blood flow and Vo 2 responses, 47 the present findings suggest that this slowing is, at least in part, due to a slowing of the second phase of hyperaemia. Impeding Vo 2 after the onset of exercise exaggerates the fall in muscle PCr and pH, increase in P i and loss of force production. [48] [49] [50] [51] Therefore, it is likely that the slowing of the hyperaemic response (phase 2) contributes directly to the abnormal metabolic responses in contracting muscle and the loss of exercise tolerance in type 2 diabetes. 1-4, 6, 46 
Limitations
Although the resting ankle-brachial pressure index is a criterion measure of peripheral arterial disease, it can be inaccurate in diabetic subjects because of the presence of arterial calcification and the associated stiffening. Angiography or Doppler ultrasound was not performed in this study and so we cannot rule out the presence of clinically significant macrovascular disease and its potential influence on the slowed hyperaemic response in the diabetic subjects. Both pre-and post-menopausal women were studied and menopause appears to reduce endothelial-dependent vasodilation. 52 However, this is unlikely to have introduced bias in the results given that the distribution of pre-and postmenopausal women was similar in the three groups. The accuracy of plethysmographic measurements of leg blood flow has been questioned. 53, 54 However, recent work from one of our laboratories shows very close agreement between plethysmographic and Doppler ultrasound estimates of leg blood flow during calf exercise. 55 
Conclusion
In conclusion, the present findings demonstrate a slowing of the hyperaemic response during calf exercise in type 2 diabetes that is attributed to the second phase of this response. This lays a foundation for further human research into the mechanisms underlying this effect and their impact on metabolic control and exercise tolerance in type 2 diabetes.
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